MAPLE ACCESS PARTNERSHIP LLP
MAPLE HOUSE, 17-19 HAZELWOOD ROAD, NORTHAMPTON
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 2 | 2 | 100.0% | |
| HF 4 | 2011 | 3 | 4 | 75.0% | |
| HF 4 | 2012 | 1 | 1 | 100.0% | |
| HF 4 | 2013 | 2 | 3 | 66.7% | |
| HF004 | 2014 | 2 | 2 | 100.0% | |
| HF004 | 2015 | 3 | 3 | 100.0% | |
| HF004 | 2016 | 6 | 6 | 100.0% | |
| HF004 | 2017 | 6 | 6 | 100.0% | |
| HF004 | 2018 | 5 | 5 | 100.0% | |
| HF004 | 2019 | 4 | 4 | 100.0% | |
| HF004 | 2020 | 3 | 3 | 100.0% | |
| HF006 | 2021 | 4 | 4 | 100.0% | |
| HF006 | 2022 | 9 | 9 | 100.0% | |
| HF006 | 2023 | 13 | 13 | 100.0% |
